logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Genomics
Filter

Genomics

Categories

Sectors

Locations

Exchange

医疗保健精选——赛诺菲与BARDA合作研究冠状病毒疫苗,吉利德冠状病毒药物研究进展缓慢

Healthcare Roundup- Sanofi teams up with BARDA on coronavirus vaccine, Studies of Gilead coronavirus drug proceeding slowly  

Feb 18, 2020

Life Science

新冠肺炎康复者血浆能有效杀死新冠病毒!

China Develops Convalescent Plasma Therapy for COVID-19 Patients

Feb 13, 2020

Life Science

爱格升和英迈中国合作,捐赠医疗推车抗击冠状病毒爆发

Ergotron and Ingram Micro Partner to Donate Medical Carts to Aid in Coronavirus Outbreak

Feb 12, 2020

Life Science

医疗保健精选——Vir Biotech识别冠状病毒结合抗体,FDA批准百特的代谢监测装置

Healthcare Roundup – Vir Biotech IDs coronavirus-binding antibodies, FDA clears Baxter metabolic monitoring device

Feb 12, 2020

Life Science

美国借贷中心率先援助大量物资,抗击武汉冠状病毒

EB-5 Industry Leader ALC Spearheads Medical Donations and Support to Help Fight Wuhan Coronavirus

Feb 6, 2020

Life Science

中国冠状病毒最新播报:继续传播,已有婴儿感染

China Coronavirus Update: Continued Spread, Run on Antivirals and Facemasks, Baby Diagnosed

Feb 6, 2020

Life Science

华为、阿里巴巴部署人工智能,快速发现冠状病毒

Huawei, Alibaba Deploy AI to Quickly Spot Coronavirus Cases, Useful Drugs

Feb 6, 2020

Life Science, Technology

比尔和梅琳达·盖茨基金会出资,助力抗击新型冠状病毒

Bill & Melinda Gates Foundation Dedicates Additional Funding to the Novel Coronavirus Response

Feb 5, 2020

Life Science

中国武汉病毒所申请抗冠状病毒“神药”瑞得西韦的专利,是否抢注成热议

China’s Wuhan Institute Files to Patent the Use of Gilead’s Remdesivir for Coronavirus

Feb 5, 2020

Life Science

Gilead Starts China Phase III Trial of Remdesivir in Coronavirus Patients

Feb 4, 2020

Life Science

医疗保健精选——百时美施贵宝和BioMotiv成立新药合资企业,百特获得内毒素过滤器的许可授权

Healthcare Roundup – Bristol-Myers and BioMotiv launch new drug venture, Baxter in-licenses rights to endotoxin filter

Feb 4, 2020

Life Science

AntiCancer Inc.口服重组蛋氨酸酶有望杀死2019-nCoV冠状病毒

AntiCancer Inc. to Target Its Oral Recombinant Methioninase Against 2019-nCoV Coronavirus

Feb 3, 2020

Technology

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Commercial-Grade Replicel Injectors RepliCel in Production

Feb 3, 2020

Technology

中国江苏省开发快速鉴定新型冠状病毒的检测试剂盒

Jiangsu Province Develops Test Kit for Rapid Identification of Novel Coronavirus

Jan 31, 2020

Life Science

医疗保健精选——强生疫苗对决冠状病毒,Selecta Biosciences下跌5.17%

Healthcare Roundup – J&J enters coronavirus fray with planned vaccine, Selecta Biosciences -5.7%

Jan 29, 2020

Life Science

冠状病毒恐惧情绪,香港股市应声下跌近3%

Hong Kong Stock Market Dives Nearly 3% on Coronavirus Fears

Jan 29, 2020

Life Science

控制冠状病毒爆发,中国科学家全力以赴

Chinese Scientists Provide Support to Control Coronavirus Outbreak

Jan 27, 2020

Life Science

默克的Keytruda迎挑战,百济神州Tislelizumab鳞状非小细胞肺癌

BeiGene’s Tislelizumab Could Challenge Merck’s Keytruda in the Checkpoint Inhibitor Market

Jan 24, 2020

Life Science

  • ‹‹ Previous
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada